This report aims to provide detailed insights into the global Clinical Documentation Improvement Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth:
The mid-revenue cycle management/clinical documentation improvement market is projected to reach USD 4.5 billion by 2023 from USD 3.1 billion in 2018, at a CAGR of 7.9%.
Market growth is largely driven by the increasing utilization of mid-RCM solutions to reduce healthcare costs, check the loss of revenue due to medical billing and coding errors, resolve issues raised by the decline in reimbursement rates, manage ever-increasing amounts of unstructured data, and maintain regulatory compliance.
3M (US), Optum (US), and Nuance (US) are the leading players in the mid-revenue cycle management /clinical documentation improvement market. The companies are mainly focusing on agreements, collaborations, partnerships, product launches & enhancements, and acquisitions to maintain and enhance their presence in the market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=120216147

Key Market Players
Prominent players in this market are 3M Company (US), Optum (US), Nuance (US), M*Modal (US), nThrive (US), Dolbey Systems (US), Streamline Health (US), Vitalware (US), Chartwise (US), Craneware (US), Epic Systems (US), Cerner (US), eZDI Inc. (US),Iodine Software (US), Flash Code (US), and TruCode (US).
The solutions segment to hold the largest share of the market in 2018.
On the basis of product & service, the mid-revenue cycle management/clinical documentation improvement market is segmented into solutions and consulting services. In 2017, solutions accounted for the largest share of the mid-revenue cycle management solutions market. The large share of the solutions segment can be attributed to the benefits offered by mid-revenue cycle solutions when they are integrated with EHRs/EMRs, encoder systems, voice/text/speech recognition software, CDI, transcription systems, and other hospital information management systems. Moreover, these solutions also eliminate the duplication of administrative work of entering selected codes into each record. They also decrease the potential for data documentation, charge capture, and coding errors, and improve the overall mid-revenue cycle process.
The clinical coding segment accounted for the largest share of the market in 2017.
The mid-revenue cycle management solutions market is further segmented into clinical documentation, clinical coding, charge capture, clinical documentation improvement (CDI), pre-bill review, and disease-related grouping (DRG). The clinical coding segment accounted for the largest market share in 2017. Clinical coding solutions are increasingly being used as an effective tool to maximize the revenue of organizations by reducing coding errors and minimizing the claims reimbursement cycle. Clinical coding solutions are a highly cost-effective method of improving revenue cycle productivity, as they help in reducing or eliminating coding errors associated with manual coding practices and help streamline the workflow within a healthcare organization.

North America dominated the market in 2017.
In 2017, North America accounted for a major share of the market. The market is well-established in North America, with the US dominating the market in this region. The healthcare insurance industry in the US, with programs such as Medicare and Medicaid, plays a primary role in the country’s healthcare delivery system. More recently, the demand for advanced computer-assisted coding systems in the country has increased due to the implementation of ICD-10 coding standards. The enhanced data provided by ICD-10 leads to better insights about health conditions and care management, better predictive analytics, and, ultimately, improved health outcomes. Growth in this market is also supported by the trend of decreasing reimbursement rates in the US.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=120216147

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441